North Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$268K Hold
230
– – 0.19% 73
2026
Q2
$276K Hold
230
– – 0.21% 76
2026
Q1
$212K Hold
230
– – 0.18% 89
2025
Q4
$247K Sell
230
-1
-0.4% -$956 0.21% 74
2025
Q3
$176K Buy
231
+1
+0.4% +$744 0.14% 95
2025
Q2
$179K Hold
230
– – 0.15% 84
2025
Q1
$190K Buy
+230
New +$191K 0.18% 76

Other funds holding LLY

North Capital's LLY Position: Q3 2026 in Review

North Capital held its Eli Lilly (LLY) position steady in Q3 2026 at 230 shares worth $268K. The position accounts for 0.19% of the portfolio, ranked #73.

North Capital first reported a position in LLY in Q1 2025 and has held it in 7 quarters since. The position peaked at $276K in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • North Capital held 230 shares of Eli Lilly worth $268K as of Q3 2026.
  • North Capital left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.19% of North Capital's portfolio in Q3 2026, its #73 holding.
  • North Capital first reported a position in Eli Lilly in Q1 2025 and has held it in 7 quarters since.
  • North Capital's Eli Lilly position peaked at $276K in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on North Capital's 13F filing for Q3 2026, filed 16 Oct 2026.